9 April 2013 -- The Regulatory Affairs Professionals Society (RAPS) will host a webcast, 10 April at 11:00 am EDT, examining and clarifying the China Food and Drug Administration’s (CFDA) medical device registration process.
John Beasley, founder and senior consultant, MedTech Review LLC, and Daniel Huang, regulatory affairs officer, Celestica (Suzhou) Technology Co. Ltd, will examine real working experiences and specific cultural and technical challenges in obtaining medical device certification in China. The presenters will review the CFDA medical device registration process step by step, and provide real examples from successful registrations.
• John Beasley, founder and senior consultant, MedTech Review LLC
• Daniel Huang, regulatory affairs officer, Celestica (Suzhou) Technology Co. Ltd
90-minute webcast entitled CFDA’s (Transparent) Process of Medical Device Registration
10 April, 11:00 am–12:30 pm EDT
How to Access:
Members of the working media may request access to this live RAPS webcast or to the recording by contacting Zachary Brousseau, senior manager, communications, RAPS, at firstname.lastname@example.org or +1 301 770 2920, ext. 245.
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Europe and Asia, and chapters and affiliates worldwide. RAPS.org